CSTF2 has previously been implicated as a promoter of lung and bladder cancer, through the regulation of ERBB2 and RAC1 3′ UTRs, respectively (Chen et al. 2018b; Mitra et al. 2018). This evidence concerns the gene ERBB2 and urinary bladder carcinoma.